Advertisement

The role of alterations in free radical metabolism in mediating cognitive impairments in Down’s syndrome

  • Karen L. Brugge
  • Sharon Nichols
  • Dean Delis
  • Tsunao Saitoh
  • Doris Truaner
Part of the EXS book series (EXS, volume 62)

Summary

Down’s syndrome (DS) is a genetic disorder involving an excess of chromosome 21 (trisomy 21) in approximately 96% of the cases and comprises approximately 15% of the population with mental retardation (Heller, 1969). In addition to the constitutional mental deficiencies associated with the syndrome many DS patients develop dementia associated with Alzheimer’s disease (AD) in their later years of life (Thase et al., 1984). The genetic locus for Cu,Zn-superoxide dismutase (SOD1), a key enzyme in free radical metabolism, is located on chromosome 21, and the activity level of this enzyme is elevated by approximately 50% in a variety of cells of DS patients (see Kedziora and Bartosz, 1988; Sinet, 1982). Because alterations in free radical metabolism may be involved in neuronal death and may be associated with a number of pathological manifestations of DS, it is important to understand the role of free radical metabolism in cognitive impairments of DS, the topic discussed in this chapter.

Keywords

Down Syndrome Intelligence Quotient GSHPx Activity Intrusion Error Copper Zinc Superoxide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ammeren, K., and Epstein, C. (1987) Lipid peroxidation and superoxide dismutase-1 and glutathione peroxidase activities in trisomy 21 fetal mice and human trisomy 21 fibroblasts. Pediatry. Res. 21: 88–92.CrossRefGoogle Scholar
  2. Brooksbank, B., and Balazs, R. (1984) Superoxide dismutase, glutathione peroxides and lipoperoxidation in Down’s syndrome fetal brain. Dev. Brain Res. 16: 37–44.CrossRefGoogle Scholar
  3. Brun, A. (1983) An overview of light and electron microscopic changes, in: Alzheimer’s Disease. The Stanford Reference. B. Reisberg, ed. HHHThe Free Press, A Division of MacMillan Inc., pp. 37–47.Google Scholar
  4. Butters, N., Granholm, E., Salmon, D., and Grant, I. (1987) Episodic and semantic memory: a comparison of amnesic and demented patients. J. Chn. Exp. Neuropsychol. 5: 479–497.CrossRefGoogle Scholar
  5. Ceballos, I., Delabar, J., Nicole, A., Lynch, R., Hallewell, R., Kamoun, P., and Sinet, P. (1988) Expression of transfected human CuZn superoxide dismutase gene in mouse L cells and NS20Y neuroblastoma cells induces enhancement of glutathione peroxidase activity. Biochim biophys. Acta 949: 58–64.PubMedGoogle Scholar
  6. Ceballos, I., Nicole, A., Briand, P., Grimber, G., Delacourte, A., et al. (1991a) Expression of human Cu-Zn superoxide dismutase gene in transgenic mice: model for gene dosage effect in Down syndrome. Free Rad. Res. Comm. 12–13: 581–589.CrossRefGoogle Scholar
  7. Ceballos, I., Javoy-Agid, F., Delacourte, A., Defossez, A., et al. (1991b) Neuronal localization of copper-zinc superoxide dismutase protein and mRNA within the human hippocampus from control and Alzheimer’s disease brains. Free Rad. Res. Conmi. 12–13: 571–580.CrossRefGoogle Scholar
  8. Clausen, J. (1984) Demential syndromes and the hpid metabohsm. Acta Neurol. Scand. 70: 345–355.PubMedCrossRefGoogle Scholar
  9. Delacourte, A., Defossez, A., Ceballos, I., Nicole, A., and Sinet, P. (1988) Preferential localization of copper zinc superoxide dismutase in the vulnerable cortical neurons in Alzheimer’s disease. Neuroscience Lett. 92: 247–253.CrossRefGoogle Scholar
  10. Floyd, R., Zaleska, M., and Harmon, J. (1984) Possible involvement of iron and oxygen free radicals in aspects of aging in brain, in: Free Radicals in Human Biology, Aging and Disease. Armstrong, D., Sohal, R. and Slater, T., eds. HHHRaven Press, pp. 143–161.Google Scholar
  11. Groner, Y., Elroy-Stein, O., Bernstein, Y., Dafni, N., Levanon, D., Danciger, E., and Neer, A. (1986) Molecular genetics of Down’s syndrome: overexpression of transfected human Cu/Zn-superoxide dismutase gene and the consequent physiological changes. Cold Spring Harbor Symposia on Quant. Bio. 11: 381–393.CrossRefGoogle Scholar
  12. Harman, D. (1983) Free radical theory of aging: consequences of mitochondrial aging. Age 6: 86–94.CrossRefGoogle Scholar
  13. Halliwell, B. (1989) Oxidants and the central nervous system: some fundamental questions. Acta Neurol. Scand. 126: 23–33.CrossRefGoogle Scholar
  14. Heller, J. (1969) Human chromosome aberrations as related to physical and mental dysfunction. J. Hered. 60: 239–248.PubMedGoogle Scholar
  15. Jaendel, C., Nicolas, M., Dubois, F., Nabet-Belleville, F., Penin, F., and Cuny, G. (1989) Lipid peroxidation and free radical scavengers in Alzheimer’s disease. Gerontology 35: 275–282.CrossRefGoogle Scholar
  16. Katzman, R., and Saitoh, T. (1991) Advances in Alzheimer’s disease. FASEB 5: 278–286.Google Scholar
  17. Kedziora, J., and Bartosz, G. (1988) Down’s syndrome: a pathology involving the lack of balance of reactive oxygen species. Free. Rad. Bio. Med. 4: 317–330.CrossRefGoogle Scholar
  18. Mann, D. (1988) The pathological association between Down’s syndrome and Alzheimer’s disease. Mech. Ageing Dev. 43: 99–136.PubMedCrossRefGoogle Scholar
  19. Marklund, S., Adolfsson, R., Gottries, C. G., and Winblad, B. (1985) Superoxide dismutase isoenzymes in normal brains and in brains from patients with dementia of Alzheimer type. J. Neurol. Sci. 67: 319–325.PubMedCrossRefGoogle Scholar
  20. Martin, G. (1976) Genetics syndrome in man with potential relevance to the pathobiology of aging, in: Genetic Effects on Aging. Bergsma, P. and Harrison, D., Eds. Alan Liss Inc., NY, pp. 5–39.Google Scholar
  21. Marx, J. (1991) Mutation identified as a possible cause of Alzheimer’s disease. Science 251 (4996): 876–877.PubMedCrossRefGoogle Scholar
  22. Misra, H., and Fridovich, I. (1976) Superoxide dismutase and the oxygen enhancement of radiation lethahty. Archs Biochem. Biophys. 176: 577–581.CrossRefGoogle Scholar
  23. Mizuno, Y., and Ohta, K. (1986) Regional distributions of thiobarbi turic acid-reactive products, activities of enzymes regulating the metabolism of oxygen free radicals, and some of the related enzymes in adult and aged rat brains. J. Neurochem. 46(5): 1344–1352.PubMedCrossRefGoogle Scholar
  24. Percy, M., Dalton, A., Markovic, V., Crapper McLachlan, D., Hummel, J. Rusk, K., and Andrews, D. (1990) Red cell superoxide dismutase, glutathione peroxidase and catalase in Down syndrome patients with and without manifestations of Alzheimer disease. Amer. J. Med. Genetics 35: 459–467.CrossRefGoogle Scholar
  25. Perrin, R., Briancon, S., Jeandel, C., Artur, Y., Minn, A., Penin, F., and Siest, G. (1990) Blood activity of Cu/Zn superoxide dismutase, glutathione peroxidase and catalase in Alzheimer’s disease: a case-control study. Gerontology 36: 306–313.PubMedCrossRefGoogle Scholar
  26. Petkau, A. (1978) Radiation protection by superoxide. Photobiology 28: 765–774.CrossRefGoogle Scholar
  27. Shah, S. (1979) Fatty acid composition of Hpids of human brain myehn and synaptosomes: changes in phenylketonuria and Down’s syndrome. Int. J. Biochem. 10: 477–482.PubMedCrossRefGoogle Scholar
  28. Sinet, P., Lejeune, J., and Jerome, H. (1979) Trisomy 21 (Down’s syndrome) glutathione peroxidase, hexose monophosphate shunt and I.Q. Life Sci. 24: 29–34.PubMedCrossRefGoogle Scholar
  29. Sinet, P. (1982) Metabolism of oxygen derivatives in Down’s syndrome. N.Y. Acad. Sci. 396: 83–94.CrossRefGoogle Scholar
  30. Southern, P., and Powis, G. (1988) Free radicals in medicine. I. Chemical nature and biological reactions. Mayo Clin. Proc. 63: 381–389.Google Scholar
  31. Sulkava, R., Nordberg, U., Erkinjuntti, T., and Westermarck, T. (1986) Erythrocyte glutathione peroxidase and superoxide dismutase in Alzheimer’s disease and other dementias. Acta Neurol. Scand. 73: 487–489PubMedCrossRefGoogle Scholar
  32. Subbarao, K., Richardson, S., and Ang, L. (1990) Autopsy samples of Alzheimer’s cortex show increased peroxidation in vitro. J. Neurochem. 55 (1): 342–345.Google Scholar
  33. Thase, M., Tigner, R., Smeltzer, D., and Liss, L. (1984) Age-related neuropsychological deficits in Down’s syndrome. Biol. Psychiat. 19(4): 571–585.PubMedGoogle Scholar
  34. Zemlan, F., Thienhaus, O., and Bosmann, H. (1989) Superoxide dismutase activity in Alzheimer’s disease: possible mechanism for paired helical filament formation. Brain Res. 476: 160–162.PubMedCrossRefGoogle Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 1992

Authors and Affiliations

  • Karen L. Brugge
    • 1
  • Sharon Nichols
    • 1
  • Dean Delis
    • 1
  • Tsunao Saitoh
    • 1
  • Doris Truaner
    • 1
  1. 1.Department of Neuroscience’s and Department of PsychiatryUniversity of CaliforniaSan DiegoUSA

Personalised recommendations